212 filings
Page 6 of 11
8-K
6t9zz5uyj4yzzgzn
7 Jun 16
Enzo Biochem Announces New York State Approval
12:00am
8-K
x4b8enl9czs9d
16 May 16
Enzo Biochem’s Life Sciences Unit Reaches $35 Million Patent Infringement Settlement in Delaware
12:00am
8-K
f8jvgurnmoian6
10 Mar 16
Enzo Biochem Submits Ampiprobe™ Based Assay Targeted at Women’s Health for Approval to New York State Department of Health
12:00am
8-K
ieegd3 kwggnl
9 Mar 16
Enzo Biochem Reports Increased Fiscal Second Quarter Results
12:00am
8-K
sfrjsz k2lt
24 Feb 16
Other Events
12:00am
8-K
4eyl5 lduciuqf
26 Jan 16
Enzo Biochem Collects $7 Million from Court Approved Escrow Fund Closings
12:00am
8-K
ing z68war8h0e38mds
8 Jan 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
rpi0dj92svmm 9y
6 Jan 16
Other Events
12:00am
8-K
re5q 154u
6 Jan 16
Enzo Biochem Updates Corporate Developments at Annual Shareholders Meeting
12:00am
8-K
djzjt 7it
30 Dec 15
Enzo Comments on Lone Star’s Decision to Withdraw Its Proxy Contest
12:00am
8-K
rpwar5g33jlqnqw
28 Dec 15
Regulation FD Disclosure
12:00am
8-K
lytos8ijfkfyrl9cs870
23 Dec 15
Regulation FD Disclosure
12:00am
8-K
xrrtszlx
23 Dec 15
Enzo Biochem Issues Open Letter to Shareholders
12:00am
8-K
jpihqu
21 Dec 15
December 2015 www.enzo.com December Investor Presentation – As Updated on December 21 st , 2015
12:00am
8-K
295dikvyyr2s
10 Dec 15
December 2015 www.enzo.com December Investor Presentation
12:00am
8-K
f538 a0fqzgz5s2dzh1
7 Dec 15
Enzo Biochem Reports Strong First Quarter
12:00am
8-K
p18dzph nkw
27 Nov 15
Enzo Biochem Releases New Investor Presentation on Corporate Strategy
12:00am
8-K
7zeaa47qc796
17 Nov 15
Hepatitis C Virus (HCV) Quantitative Test to be Offered to Physicians and Clinical Laboratory Market Nationwide
12:00am
8-K
qx292e
13 Oct 15
Enzo Biochem Reports Strong Fourth Quarter Results
12:00am
8-K/A
mvkft8
4 Sep 15
Financial Statements and Exhibits
12:00am